NCT lookup
Pull any trial record directly from ClinicalTrials.gov.
Sponsor: University of Arkansas
Conditions: Autism Spectrum Disorder, Autism, Mitochondrial Disease, Developmental Delay
Countries: United States
Researchers at Arkansas Children's Hospital Research Institute are conducting a study about mitochondrial function in children. The study involves up to 5 visits to Arkansas Children's Hospital with fasting blood draws, behavioral assessments, and/or questionnaires. This study is not currently recruiting, but continues to follow those who were enrolled. There is no cost for visits or study-related exams. For further information, please contact the program manager, Leanna Delhey, at ldelhey@uams.edu or 501-364-4519
Sex: ALL
Age: 0 Years to 17 Years
Healthy volunteers: Yes
Study type: OBSERVATIONAL
Inclusion Criteria: Inclusion Criteria for ASD children 1. Autism Spectrum Disorder (As defined by a gold standard measure for ASD diagnosis: the Autism Diagnostic Observation Schedule, Autism Diagnostic Interview, and/or the minimum Arkansas state requirement for autism classification, as defined by a consensus diagnosis of ASD by a medical doctor, speech pathologist, and psychologist.). In an event where sufficient diagnostic information is lacking, and the PI believes that the clients meet all other inclusion criteria and a prospective diagnosis of an ASD is clinically warranted, and a formal diagnosis is scheduled to occur within a reasonable time frame from the date of study entry, then the client may be considered as potentially eligible. 2. 0 years through 17 years 11 months of age Inclusion Criteria for TD children 1\. 0 years to 17 years 11 months of age Exclusion Criteria: * Discussed on a case by case basis
- Memphis, Tennessee, United States